中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:( Hongqing CHENG)

1.Analysis of 557 Cases with Adverse Drug Reaction in Our Hospital

Suying YAN ; Hongqing CHENG ; Yan ZENG ; Lianzheng CHENG

China Pharmacy 2005;0(18):-

2.Significance of β-catenin and Cyclin D1 express in glioma

Zhiqiang ZHANG ; Hongqing CHEN ; Yinghong CHEN ; Xinfu CHENG

Journal of Cellular and Molecular Immunology 2009;25(11):1010-1012

3.Treatment for Brain Metastases from EGFR Mutations NSCLC Patients: How Should We Choose in Clinical Practice?

Cheng CHENG ; Hongqing ZHUANG

Chinese Journal of Lung Cancer 2020;23(8):631-637

4.Construction and expression of humanized anti-HBsAg scFv targeting interferon-alpha in escherichia coli.

Xiaobing XIA ; Jun CHENG ; Jizhen YANG ; Yanwei ZHONG ; Gang WANG ; Hongqing FANG ; Yan LIU ; Ke LI ; Jing DONG

Chinese Journal of Hepatology 2002;10(1):28-30

5.Evaluation on urodynamics of the partial bladder outlet obstruction model

Jun GONG ; Wen CHENG ; Jianping GAO ; Zhengyu ZHANG ; Jinping GE ; Shuigen ZHOU ; Wenquan ZHOU ; Hongqing MA ; Wu WEI ; Song XUE ; Zhenyu XU ; Dong WANG ; Song XU

Journal of Medical Postgraduates 2003;0(07):-

6.Utilization rate of gold fiducial markers and reasons for abandonment in CyberKnife stereotactic body radiation therapy

Fei XU ; Fuxin GUO ; Ran PENG ; Xile ZHANG ; Hongqing ZHUANG ; Ping JIANG ; Jinghong FAN ; Weiyan LI ; Yuliang JIANG ; Zhe JI ; Haitao SUN ; Cheng CHENG ; Junjie WANG

Chinese Journal of Radiation Oncology 2018;27(3):295-298

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO